Potential Role of microRNA 410 and BIRC7 Pathways in Recurrent Spontaneous Miscarriage
microRNA410
1 other identifier
observational
86
1 country
1
Brief Summary
The definition of recurrent spontaneous abortion (RSA) has changed over the years, and most societies now advocate defining RSA as two or three consecutive or discontinuous miscarriages with the same sexual partner before 24 weeks gestation In recent years, the incidence of this disease has been on the rise, occurring in about 1%- 5% of pregnancy in women at childbearing age, and the success rate of second pregnancy in RSA females has been significantly reduced The etiology of RSA is extremely complex, including anatomical factors, genetic factors, endocrine factors, infectious and immune factors, and pre-thrombosis etiology. However, the cause of the disease is unclear in half of patients and known as unexplained recurrent spontaneous abortion (URSA)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2022
CompletedFirst Posted
Study publicly available on registry
December 20, 2022
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedDecember 31, 2025
December 1, 2023
2.2 years
December 12, 2022
December 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Define a novel hypothesis that may explain the aetiology of URSA
within 3 years
Study Arms (2)
cases
Female with recurrent unexplained abortion
control
female with normal labour
Interventions
Eligibility Criteria
Female without cancer or chronic illness that exposed to 2 or 3 consecutive or discontinues abortion
You may qualify if:
- Female with unexplained two or three consecutive or discontinuous miscarriages with the same sexual partner
You may not qualify if:
- Female with one miscarriage
- Female with explained causes of miscarriage
- Female with cancer
- Female with chronic illness.
- Pregnant women above 30
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical Bochemistry Department
Asyut, Assuit, Egypt
Biospecimen
placental samples (4×6 cm) will be collected from women with miscarriage. Placental tissue from healthy controls (females with normal or caesarean labour)will also be collected. Tissue samples will be removed from the central region of the placenta and processed within 30 min. All samples will be repeatedly rinsed with cold phosphate buffered saline (PBS), and maintained at -80 °C until genetic study of miR-410-5p expression, Integrin alpha-6gene expression and Baculoviral IAP Repeat Containing 7(BIRC7) expression by qRTPCR.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- faculty of medicine Assuit university
Study Record Dates
First Submitted
December 12, 2022
First Posted
December 20, 2022
Study Start
January 1, 2023
Primary Completion
April 1, 2025
Study Completion
June 1, 2025
Last Updated
December 31, 2025
Record last verified: 2023-12